Overview

Atrial Fibrillation and Neuropathic Pain After Thoracotomy and Continuous Application of Magnesium Sulphate.

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
0
Participant gender:
All
Summary
Atrial fibrillation and chronic neuropathic pain are adverse events occurring after posterolateral thoracotomy for lung resection. The continuous application of magnesium sulphate may have a prophylactic effect. The investigators record the incidence of atrial fibrillation during a seven day period after thoracotomy as well as the incidence of chronic neuropathic pain during a three months period, comparing one group with a continuous application of magnesium sulphate against one group without magnesium sulphate.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Dr. Horst Schmidt Klinik GmbH
Treatments:
Magnesium Sulfate
Criteria
Inclusion Criteria:

- 18 years or older

- posterolateral thoracotomy for lung parenchyma resection

- informed consent

Exclusion Criteria:

- hypersensitivity for magnesium sulphate

- pre-existing atrial fibrillation

- participation in another trial

- pregnancy or breastfeeding